-
2
-
-
79959952948
-
TET2 mutations in secondary acute myeloid leukemias: A French retrospective study
-
Kosmider O, Delabesse E, de Mas VM, Cornillet-Lefebvre P, Blanchet O, Delmer A et al. TET2 mutations in secondary acute myeloid leukemias: a French retrospective study. Haematologica 2011; 96: 1059-1063.
-
(2011)
Haematologica
, vol.96
, pp. 1059-1063
-
-
Kosmider, O.1
Delabesse, E.2
De Mas, V.M.3
Cornillet-Lefebvre, P.4
Blanchet, O.5
Delmer, A.6
-
3
-
-
84865210203
-
Similarities and differences between therapy-related and elderly acute myeloid leukemia
-
D'Alò F, Fianchi L, Fabiani E, Criscuolo M, Greco M, Guidi F et al. Similarities and differences between therapy-related and elderly acute myeloid leukemia. Mediterr J Hematol Infect Dis 2011; 3: e2011052.
-
(2011)
Mediterr J Hematol Infect Dis
, vol.3
-
-
D'Alò, F.1
Fianchi, L.2
Fabiani, E.3
Criscuolo, M.4
Greco, M.5
Guidi, F.6
-
4
-
-
84863337757
-
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells
-
Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 2012; 21: 430-446.
-
(2012)
Cancer Cell
, vol.21
, pp. 430-446
-
-
Tsai, H.C.1
Li, H.2
Van Neste, L.3
Cai, Y.4
Robert, C.5
Rassool, F.V.6
-
5
-
-
70350720044
-
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
-
Figueroa ME, Skrabanek L, Li Y, Jiemjit A, Fandy TE, Paietta E et al. MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 2009; 114: 3448-3458.
-
(2009)
Blood
, vol.114
, pp. 3448-3458
-
-
Figueroa, M.E.1
Skrabanek, L.2
Li, Y.3
Jiemjit, A.4
Fandy, T.E.5
Paietta, E.6
-
6
-
-
60849089645
-
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
-
Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C et al. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 2009; 113: 1315-1325.
-
(2009)
Blood
, vol.113
, pp. 1315-1325
-
-
Jiang, Y.1
Dunbar, A.2
Gondek, L.P.3
Mohan, S.4
Rataul, M.5
O'Keefe, C.6
-
7
-
-
77956870600
-
Promoter methylation of DAPK1. E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms
-
Greco M, D'Alò F, Scardocci A, Criscuolo M, Fabiani E, Guidi F et al. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms. Blood Cells Mol Dis 2010; 45: 181-185.
-
(2010)
Blood Cells Mol Dis
, vol.45
, pp. 181-185
-
-
Greco, M.1
D'Alò, F.2
Scardocci, A.3
Criscuolo, M.4
Fabiani, E.5
Guidi, F.6
-
8
-
-
80053900941
-
Frequent pathway mutations of splicing machinery in myelodysplasia
-
Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64-69.
-
(2011)
Nature
, vol.478
, pp. 64-69
-
-
Yoshida, K.1
Sanada, M.2
Shiraishi, Y.3
Nowak, D.4
Nagata, Y.5
Yamamoto, R.6
-
9
-
-
83455234787
-
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
-
Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C et al. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood 2011; 118: 6239-6246.
-
(2011)
Blood
, vol.118
, pp. 6239-6246
-
-
Malcovati, L.1
Papaemmanuil, E.2
Bowen, D.T.3
Boultwood, J.4
Della Porta, M.G.5
Pascutto, C.6
-
10
-
-
84856477048
-
Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia
-
Fried I, Bodner C, Pichler MM, Lind K, Beham-Schmid C, Quehenberger F et al. Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia. Haematologica 2012; 97: 246-250.
-
(2012)
Haematologica
, vol.97
, pp. 246-250
-
-
Fried, I.1
Bodner, C.2
Pichler, M.M.3
Lind, K.4
Beham-Schmid, C.5
Quehenberger, F.6
-
11
-
-
84857232561
-
Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia
-
Ottone T, Cicconi L, Hasan SK, Lavorgna S, Divona M, Voso MT et al. Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia. Leuk Res 2012; 36: 474-478.
-
(2012)
Leuk Res
, vol.36
, pp. 474-478
-
-
Ottone, T.1
Cicconi, L.2
Hasan, S.K.3
Lavorgna, S.4
Divona, M.5
Voso, M.T.6
-
12
-
-
77954658823
-
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic-or blastphase essential thrombocythemia, polycythemia vera or myelofibrosis
-
Tefferi A, Lasho TL, Abdel-Wahab O, Guglielmelli P, Patel J, Caramazza D et al. IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic-or blastphase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia 2010; 24: 1302-1309.
-
(2010)
Leukemia
, vol.24
, pp. 1302-1309
-
-
Tefferi, A.1
Lasho, T.L.2
Abdel-Wahab, O.3
Guglielmelli, P.4
Patel, J.5
Caramazza, D.6
-
13
-
-
84861082246
-
Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome
-
Zhang SJ, Rampal R, Manshouri T, Patel J, Mensah N, Kayserian A et al. Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome. Blood 2012; 119: 4480-4485.
-
(2012)
Blood
, vol.119
, pp. 4480-4485
-
-
Zhang, S.J.1
Rampal, R.2
Manshouri, T.3
Patel, J.4
Mensah, N.5
Kayserian, A.6
-
14
-
-
20144389274
-
Acute leukemia in polycythemia vera: An analysis of 1638 patients enrolled in a prospective observational study
-
Finazzi G, Caruso V, Marchioli R, Capnist G, Chisesi T, Finelli C et al. Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood 2005; 105: 2664-2670.
-
(2005)
Blood
, vol.105
, pp. 2664-2670
-
-
Finazzi, G.1
Caruso, V.2
Marchioli, R.3
Capnist, G.4
Chisesi, T.5
Finelli, C.6
-
15
-
-
80053945428
-
Treatment of polycythemia vera with hydroxyurea and pipobroman: Final results of a randomized trial initiated in 1980
-
Kiladjian JJ, Chevret S, Dosquet C, Chomienne C, Rain JD. Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980. J Clin Oncol 2011; 29: 3907-3913.
-
(2011)
J Clin Oncol
, vol.29
, pp. 3907-3913
-
-
Kiladjian, J.J.1
Chevret, S.2
Dosquet, C.3
Chomienne, C.4
Rain, J.D.5
|